Experiment 1087469
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | MARANINCHI,D: GASTAUT,JA: TUBIANA,N: CARCASSONNE,Y:. (1981). CONTINUOUS 5-DAY INFUSION OF VINDESINE IN THE TREATMENT OF LEUKEMIAS AND LYMPHOMAS.. 68() |
| Amount utilized | |
| Compound isolated | |
| Disease | TREATMENT BY CONTINUOUS IV INFUSION OF VINDESINE FOR 5 DAYS IN 21 PATIENTS(5 WITH ACUTE LYMPHOBLASTIC LEUKEMIA: 6 WITH BLASTIC CRISIS OF CHRONIC MYELOCYTIC LEUKEMIA AND 10 WITH LYMPHOMAS). 13 OF 18 EVALUABLE PATIENTS HAD PARTIAL OR MINOR REGRESSIONS. TOXICITY WAS NOT IMPORTANT. TREATMENT BY CONTINUOUS IV INFUSION OF VINDESINE FOR 5 DAYS IN 21 PATIENTS(5 WITH ACUTE LYMPHOBLASTIC LEUKEMIA, 6 WITH BLASTIC CRISIS OF CHRONIC MYELOCYTIC LEUKEMIA, 11 WITH LYMPHOMAS). 13 OF 18 EVALUABLE PATIENTS HAD PARTIAL OR MINOR REGRESSIONS. TOXICITY WAS NOT IMPORTANT. TREATMENT BY CONTINUOUS IV INFUSION OF VINDESINE FOR 5 DAYS IN 21 PATIENTS(5 WITH ACUTE LYMPHOBLASTIC LEUKEMIA, 6 WITH BLASTIC CRISIS OF CHRONIC MYELOCYTIC LEUKEMIA, 11 WITH LYMPHOMAS). 13 OF 18 EVALUABLE PATIENTS HAD PARTIAL OR MINOR REGRESSIONS. TOXICITY WAS NOT IMPORTANT. TREATMENT BY CONTINUOUS IV INFUSION OF VINDESINE FOR 5 DAYS IN 21 PATIENTS(5 WITH ACUTE LYMPHOBLASTIC LEUKEMIA, 6 WITH BLASTIC CRISIS OF CHRONIC MYELOCYTIC LEUKEMIA, 11 WITH LYMPHOMAS). 13 OF 18 EVALUABLE PATIENTS HAD PARTIAL OR MINOR REGRESSIONS. TOXICITY WAS NOT IMPORTANT. |
| Dose amount | 0.7 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |